Submission Details
| 510(k) Number | K023584 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 25, 2002 |
| Decision Date | November 20, 2002 |
| Days to Decision | 26 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K023584 is an FDA 510(k) clearance for the ASCENSIA DEX 2 DIABETES CARE SYSTEM, a System, Test, Blood Glucose, Over The Counter (Class II — Special Controls, product code NBW), submitted by Bayer Corp. (Elkhart, US). The FDA issued a Cleared decision on November 20, 2002, 26 days after receiving the submission on October 25, 2002. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1345.
| 510(k) Number | K023584 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 25, 2002 |
| Decision Date | November 20, 2002 |
| Days to Decision | 26 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NBW — System, Test, Blood Glucose, Over The Counter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1345 |